Senores Pharmaceuticals Limited

₹1,194As of Sun 8 Nov 2026, 12:00 UTC
NSE:SENORESHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE 14.72%
Drug Manufacturers (General)
Beta (5Y) —
PE TTM 40.87
TSR TTM 54.82%
Mkt cap ₹54.99B
ROIC 10.57%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹1,495
25.25%
(68.32%)
Hold 2|3|8|5|11
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
14.71
14.63
15.61
15.62
23.83%
22.19%
22.26%
15.08%
Revenue₹B
4.438
4.361
4.501
4.371
8.13%
6.83%
4.56%
1.49%
Peers (US$566.5M)
Cap (US$)
PE
830.4M
27.88x
805.5M
20.75x
498.1M
39.99x
619.8M
46.76x
Capital
TTM
5Y
10Y
Leveragex
2.632
1.164
1.140
EBIT/Intx
0.870
0.057
0.063
Own earn%
96.13
(297.95)
(229.08)
Sh yield%
16.46
49.51
47.37
Owners
Insiders/Inst%
4.42
69.05
Short interest%
0.54
SBC / revenue%
3.88
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
22–30
$1 testx
0.1
Incr. ROIC%
3